Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nonpeptide Src SH2-binding compounds for osteoporosis designed at Aventis

Sep. 21, 2000

Welchol now available in U.S. for treatment of elevated cholesterol

Sep. 21, 2000

Therapies for obesity, diabetes under investigation at Dainippon

Sep. 20, 2000

AHP synthesizes and evaluates new PTPase inhibitors

Sep. 20, 2000

Several related series described by Bayer as useful for anemia Rx

Sep. 20, 2000

First selective orexin-1 receptor antagonists emerge from R&D program at SB

Sep. 20, 2000

Alphav integrin receptor antagonists claimed by Merck for inhibiting bone resorption

Sep. 19, 2000

Isoflavone-based bone resorption inhibitors presented by Chiesi in Bologna this week

Sep. 19, 2000

Novel family of MTP inhibitors discovered at Janssen possess lipid-lowering properties

Sep. 19, 2000

Zonagen's product for FSD shows promise in clinical trial

Sep. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...